These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25 related articles for article (PubMed ID: 12460043)
1. Designing Cardiovascular Implants Taking in View the Endothelial Basement Membrane. Lau S; Gossen M; Lendlein A Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884923 [TBL] [Abstract][Full Text] [Related]
2. Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients. Jahnukainen T; Lauronen J; Raissadati A; Pihkala JI; Ylinen E; Puntila JT; Salminen JT; Pätilä T; Mattila IP; Jalanko HJ Ann Transplant; 2019 Aug; 24():454-460. PubMed ID: 31383839 [TBL] [Abstract][Full Text] [Related]
3. Tissue-Engineered Grafts from Human Decellularized Extracellular Matrices: A Systematic Review and Future Perspectives. Porzionato A; Stocco E; Barbon S; Grandi F; Macchi V; De Caro R Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567407 [TBL] [Abstract][Full Text] [Related]
4. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lawson JH; Glickman MH; Ilzecki M; Jakimowicz T; Jaroszynski A; Peden EK; Pilgrim AJ; Prichard HL; Guziewicz M; Przywara S; Szmidt J; Turek J; Witkiewicz W; Zapotoczny N; Zubilewicz T; Niklason LE Lancet; 2016 May; 387(10032):2026-34. PubMed ID: 27203778 [TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats. Splith K; Fellmer P; Matia I; Varga M; Oliverius M; Kuhn S; Feldbrügge L; Krenzien F; Hau HM; Wiltberger G; Schmelzle M; Jonas S PLoS One; 2014; 9(3):e91212. PubMed ID: 24618652 [TBL] [Abstract][Full Text] [Related]
6. eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering. McIlhenny S; Zhang P; Tulenko T; Comeau J; Fernandez S; Policha A; Ferroni M; Faul E; Bagameri G; Shapiro I; DiMuzio P J Tissue Eng Regen Med; 2015 Nov; 9(11):1277-85. PubMed ID: 23319464 [TBL] [Abstract][Full Text] [Related]
7. Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement. Yagi H; Soto-Gutierrez A; Kitagawa Y Surg Today; 2013 Jun; 43(6):587-94. PubMed ID: 23184357 [TBL] [Abstract][Full Text] [Related]
8. [Problems of surgery of vascular access for hemodialysis]. Alferov SV; Karpov SA; Grinev KM Vestn Khir Im I I Grek; 2013; 172(2):97-100. PubMed ID: 24000692 [No Abstract] [Full Text] [Related]
9. THE USE OF VEIN HOMOGRAFTS IN TYMPANOPLASTY. KING PF Ann R Coll Surg Engl; 1965 Aug; 37(2):65-92. PubMed ID: 14329873 [No Abstract] [Full Text] [Related]
10. Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation. Madden R; Lipkowitz G; Benedetto B; Kurbanov A; Miller M; Bow L Am J Kidney Dis; 2002 Dec; 40(6):1240-3. PubMed ID: 12460043 [TBL] [Abstract][Full Text] [Related]
11. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. Benedetto B; Lipkowitz G; Madden R; Kurbanov A; Hull D; Miller M; Bow L J Vasc Surg; 2001 Jul; 34(1):139-42. PubMed ID: 11436087 [TBL] [Abstract][Full Text] [Related]
12. Utility of formaldehyde-fixed arterial allografts for hemodialysis access. Roy-Chaudhury P Nat Clin Pract Nephrol; 2008 Feb; 4(2):74-5. PubMed ID: 18030292 [No Abstract] [Full Text] [Related]